Insider transactions

James B Hawkins

CIK 898243 · President and CEO · last filed 2026-10-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$9.45M
Companies
8
Total Filings
171
Lifetime Open-Market Net
-$47.98M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

BABY price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS, FL 32708
Related Filers
STAR EQUITY HOLDINGS, INC. — 7 joint filings, latest 2014-08-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AEYE Director 218,684 $9.94 $2.17M $775.3K 22 2026-10-02
OSIS Director 5,295 $202.03 $1.07M -$2.13M 28 2026-08-21
IRMD Director 29,647 $83.91 $2.49M -$7.78M 32 2025-12-15
CZR Director 128,082 $28.89 $3.70M $0 1 2020-07-22
Caesars Entertainment, Inc. (ERI) Delisted Director 125,137 — — $1.05M 19 2020-01-28
NATUS MEDICAL INC (BABY) Delisted President and CEO 639,257 — — -$39.89M 44 2018-05-02
IRIX Director 31,294 $0.76 $23.6K -$121.4K 10 2014-08-22
STAR EQUITY HOLDINGS, INC. (DRAD) Delisted Director 12,470 — — $125.7K 5 2014-08-08

Recent Filings · Page 10 of 18

171 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-09-05 Caesars Entertainment, Inc. (ERI) Delisted Buy (P) +1,000 $46.5K EDGAR
2018-08-07 Caesars Entertainment, Inc. (ERI) Delisted Buy (P) +4,000 $169.8K EDGAR
2018-07-10 OSIS Grant (A) +2,225 $0 EDGAR
2018-05-02 NATUS MEDICAL INC (BABY) Delisted Mixed — -$3.64M EDGAR
2018-01-30 Caesars Entertainment, Inc. (ERI) Delisted Grant (A) — $0 EDGAR
2018-01-03 NATUS MEDICAL INC (BABY) Delisted Mixed +71,017 $2.71M EDGAR
2017-08-24 OSIS Grant (A) +2,147 $0 EDGAR
2017-08-17 NATUS MEDICAL INC (BABY) Delisted Tax (F) −9,783 -$334.1K EDGAR
2017-06-15 NATUS MEDICAL INC (BABY) Delisted Buy (P) +4,000 $135.9K EDGAR
2017-05-31 NATUS MEDICAL INC (BABY) Delisted Buy (P) +6,000 $202.9K EDGAR
Showing 91–100 of 171
Page 10 of 18
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.